SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-23-115814
Filing Date
2023-11-08
Accepted
2023-11-08 17:15:36
Documents
2
Period of Report
2023-11-06

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2330155-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2330155-1_3seq1.xml 3 1661
2 EXHIBIT 24 tm2330155d1_ex24.htm EX-24 7113
  Complete submission text file 0001104659-23-115814.txt   10151
Mailing Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169
Business Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169 212-847-9841
Y-mAbs Therapeutics, Inc. (Issuer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169
Business Address
Rossi Michael J (Reporting) CIK: 0001948795 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38650 | Film No.: 231389252